Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1998
12/10/1998WO1998055508A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
12/10/1998WO1998055507A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998WO1998055502A1 METHODS FOR RAPID CLONING OF FULL LENGTH cDNAs
12/10/1998WO1998055495A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
12/10/1998WO1998055490A1 Novel class of nucleic acid cationic transfecting agents
12/10/1998WO1998055150A1 Txu-7-pap immunotoxin and use thereof
12/10/1998WO1998055146A1 IDENTIFICATION OF HUMAN HEAVY CHAIN ANTIBODY FRAGMENT DIRECTED AGAINST HUMAN PLATELET ALLOANTIGEN 1a(HPA-1a)
12/10/1998WO1998055145A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998WO1998055137A1 Bone morphogenetic proteins and their use in bone growth
12/10/1998WO1998055136A1 Fsh-releasing peptides
12/10/1998WO1998055132A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998WO1998055110A2 NEW USES FOR COMPOUNDS WHICH REDUCE c-jun GENE EXPRESSION
12/10/1998WO1998054980A2 Carbohydrate-based enzyme granulates
12/10/1998WO1998054963A2 207 human secreted proteins
12/10/1998WO1998054961A2 Plant transformation methods
12/10/1998WO1998054954A1 Fatty acid elongases
12/10/1998WO1998047343A3 Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
12/10/1998WO1998042831A3 Chimeric genes and methods for increasing the lysine content of the seeds of plants
12/10/1998WO1998041188A3 Stable particle in liquid formulations
12/10/1998WO1998040497A3 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
12/10/1998WO1998039472A3 Method for detecting mutated allels
12/10/1998WO1998039465A3 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
12/10/1998WO1998039429A3 Compositions for treatment of disorders involving programmed cell death
12/10/1998WO1998038339A3 Nucleic acid based detection of cytomegalovirus
12/10/1998WO1998038325A3 Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells
12/10/1998WO1998036059A3 Prion propagation inhibition by dominant-negative prion protein mutants
12/10/1998WO1998033893A3 Ribozymes cleaving epidermal growth factor receptors
12/10/1998WO1998033478A3 Rna- and dna-based active agents in nanoparticles
12/10/1998WO1998029538A3 Gene for adenylate cyclase and its use
12/10/1998WO1998022575A3 Nucleotide sequence of escherichia coli pathogenicity islands
12/10/1998DE19724039A1 DNS-Sequenzen, Expression dieser DNS-Sequenzen, durch die DNS-Sequenzen kodierte thermophile Laccasen sowie deren Verwendung DNA sequences, expression of these DNA sequences encoded by the DNA sequences and their use thermophilic laccases
12/10/1998CA2293693A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998CA2293664A1 Fsh-releasing peptides
12/10/1998CA2293296A1 Human proteins having transmembrane domains and dnas encoding these proteins
12/10/1998CA2292899A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292896A1 Attachment of unmodified nucleic acids to silanized solid phase surfaces
12/10/1998CA2292892A1 Translational regulator initiation factor 4e-binding protein
12/10/1998CA2292891A1 Zinc ring protein
12/10/1998CA2292842A1 Method for reducing expression variability of transgenes in plants cells
12/10/1998CA2292840A1 Mitofusin genes and their uses
12/10/1998CA2292838A1 Lactoferrin receptor genes of moraxella
12/10/1998CA2292837A1 Novel class of nucleic acid cationic transfecting agents
12/10/1998CA2292835A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292795A1 Indirect genotypic method for diagnosing type 2 familial hemiplegic migraine
12/10/1998CA2292778A1 Plant amino acid biosynthetic enzymes
12/10/1998CA2292770A1 Fatty acid elongases
12/10/1998CA2292766A1 Diacylglycerol acyl transferase proteins
12/10/1998CA2292760A1 Vector
12/10/1998CA2292759A1 Reagents and methods useful for detecting diseases of the urinary tract
12/10/1998CA2292728A1 A method to map and isolate regions of chromosomes that interact or associate functionally within or between chromosomes in vivo
12/10/1998CA2292723A1 Dna sequences, expression of said dna sequences, thermopile laccases coded by said dna sequences and the use thereof
12/10/1998CA2292643A1 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998CA2292426A1 Txu-7-pap immunotoxin and use thereof
12/10/1998CA2291862A1 New selection marker
12/10/1998CA2291661A1 New human ribonuclease
12/10/1998CA2291485A1 Secreted proteins and polynucleotides encoding them
12/10/1998CA2291452A1 Engineering plant thioesterases and disclosure of plant thioesterases having novel substrate specificity
12/10/1998CA2291260A1 207 human secreted proteins
12/10/1998CA2291116A1 Rapid methods for identifying modifiers of cellular apoptosis activity
12/10/1998CA2291010A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998CA2289564A1 Preparation of glycosylated tumor necrosis factor
12/10/1998CA2289491A1 Retroviral vector particles produced in a baculovirus expression system
12/10/1998CA2289479A1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998CA2288988A1 Methods for rapid cloning of full length cdnas
12/10/1998CA2287848A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998CA2283422A1 Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants
12/10/1998CA2262463A1 New uses for compounds which reduce c-jun gene expression
12/10/1998CA2262388A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method
12/10/1998CA2234423A1 Processes for preparation of marek's disease virus using continuous mammalian cell lines
12/10/1998CA2234411A1 Novel compounds
12/10/1998CA2206673A1 Use of molecular markers for genotype determination of the ogura rf gene in brassica napus
12/09/1998EP0882979A1 Electrode holder comprising at least one covered electrode and reading-out system
12/09/1998EP0882796A2 Nucleic acid molecules encoding Streptococcus pneumoniae rnc protein, and compositions comprising the same
12/09/1998EP0882795A2 Recombinant secA1 polypeptides from Staphylococcus aureus and uses thereof
12/09/1998EP0882794A2 Human complementarity determining region (CDR)-grafted antibody to ganglioside gm2
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882792A2 CSB5, a member of the guanine nucleotide exchange factor (GEF) family of polypeptides
12/09/1998EP0882791A2 WNT-11 polypeptides
12/09/1998EP0882790A1 Traf family molecule, polynucleotide coding for the molecule, and antibody against the molecule
12/09/1998EP0882228A1 Methods to identify modulators of cell signaling
12/09/1998EP0882140A2 Process for recognizing the risk of becoming ill after an arthropod bite
12/09/1998EP0882134A1 Methods and compositions for protective and therapeutic genetic immunization
12/09/1998EP0882133A1 Regulation of gene expression in eukaryotes
12/09/1998EP0882132A2 A human cytomegalovirus combined antigen and its use
12/09/1998EP0882131A1 Polypeptides having mutanase activity and nucleic acids encoding same
12/09/1998EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
12/09/1998EP0882129A1 Recombinant expression of s-layer proteins
12/09/1998EP0882128A1 Cell-based assay
12/09/1998EP0882127A1 Ungulate embryonic stem-like cells, methods of making and using the cells to produce transgenic ungulates
12/09/1998EP0882065A2 Novel human metabotropic glutamate receptor
12/09/1998EP0882060A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof
12/09/1998EP0881950A1 Temperature-regulating block with temperature-regulating devices
12/09/1998EP0881914A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression
12/09/1998EP0881913A1 Liposomal-viral dna complexes for treating disease
12/09/1998EP0881884A1 Bacterial delivery system
12/09/1998EP0776224B1 Needleless syringe for particle delivery
12/09/1998EP0689599B1 Chimeric selectins by exchange of domains - uses thereof
12/09/1998EP0636028A4 Self-assembling polynucleotide delivery system.
12/09/1998EP0566579B1 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions
12/09/1998EP0463073B1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA